Login to Your Account

CBMG takes Agreen's T cell immune therapy for $3.28M

By Shannon Ellis
Staff Writer

Wednesday, August 13, 2014
SHANGHAI – Cellular Biomedicine Group Inc., a stem cell and immunotherapy company headquartered in Shanghai, has acquired Beijing Agreen Biotech Co. Ltd. The deal will bring patents, people and the promise of revenue to its new owner.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription